Clinical Research Directory
Browse clinical research sites, groups, and studies.
Dupilumab Treatment Effects in an Ethnically Diverse Population With Chronic Rhinosinusitis With Nasal Polyposis
Sponsor: Montefiore Medical Center
Summary
The central hypothesis of this study is that the addition of dupilumab treatment onto standard-of-care intranasal corticosteroids will improve patient-reported measures of disease activity and sense of smell in a cohort of mostly ethnical and racial minority patients with CRSwNP
Official title: Dupilumab Treatment Effects in an Ethnically Diverse Population With Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP)
Key Details
Gender
All
Age Range
18 Years - 99 Years
Study Type
OBSERVATIONAL
Enrollment
60
Start Date
2022-02-15
Completion Date
2026-06
Last Updated
2026-01-22
Healthy Volunteers
No
Conditions
Interventions
Dupilumab
Standard of care treatment with dupilumab
Locations (1)
Montefiore Medical Center
The Bronx, New York, United States